Skip to main content
Caplight Logo









Wilmar Ventures

Wilmar Ventures

Overview

Wilmar Ventures is a Singapore-based investment subsidiary of the agribusiness group Wilmar International, focused on strategic investments in sectors such as foodtech, agtech, and healthcare.

Year Founded

2016

Portfolio Companies

1

Investments

Wilmar Ventures investments
CompanyDateStageLead
CerecinMay 2024Pre SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Wilmar Ventures based?

Wilmar Ventures is headquartered in Singapore, Singapore.

When was Wilmar Ventures founded?

Wilmar Ventures was founded in 2016.

How many portfolio companies does Wilmar Ventures have?

Wilmar Ventures has 1 portfolio company in Caplight's dataset.

What are some companies in Wilmar Ventures's portfolio?

Portfolio companies visible on Caplight include Cerecin.

What was Wilmar Ventures's most recent investment shown here?

Wilmar Ventures's most recent investment in this portfolio sample was in Cerecin in 2024.

What sectors does Wilmar Ventures focus on?

Wilmar Ventures focuses on Healthcare & Life Sciences.

What company stages does Wilmar Ventures focus on?

Wilmar Ventures typically invests at the Early stage.

Firmographic Details

HeadquartersSingapore
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?